Ventyx Biosciences Inc (VTYX) Company Profile & Statistics

Ventyx Biosciences Inc
VTYX
(Nasdaq - US)
Closed
43.91
+0.78 (+1.81%)
in:usd•As of: Feb 03, 2023 15:59 UTC -5
Open
42.33
High
44.56
Low
42.33

About Ventyx Biosciences Inc

CEO

Raju Mohan

Headquarters

662 encinitas blvd., ste. 250

encinitas, ca 92024, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.ventyxbio.com

Industry

biotechnology

Sector

health technology

Company Overview

Ventyx Biosciences Inc. is a clinical-stage biopharmaceutical company. It focused on advancing new therapies for patients living with inflammatory diseases and autoimmune disorders. The company's clinical stage pipeline includes VTX958, VTX002 and VTX2735. Ventyx Biosciences Inc. is headquartered in Encinitas, California.

Ventyx Biosciences Inc Statistics

Valuation Measures

Market Capitalization ²	2.49B
Enterprise Value	2.22B
Enterprise Value/EBITDA (ttm)	-24.16
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.02
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-31.24%
Return on Invested Capital (ttm)	-31.31%
Return on Assets (ttm)	-29.07%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-92.06M
Net Income Avi to Common (ttm)	-90.98M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	-0.18
52-Week Change	259.62%
S&P500 52-Week Change	-8.09%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	56.64M
Dividend Yield	0.00%
Float ⁴	28.83M
% Held by Insiders	49.10%
% Held by Institutions	95.57%

Balance Sheet

Total Cash (mrq)	412.42M
Total Cash Per Share (mrq)	7.28
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	11.73%
Quick Ratio (mrq)	11.73%
Book Value Per Share (mrq)	6.77

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.00
Free Cash Flow (ytd)	-51.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Ventyx Biosciences Inc

Trade With A Regulated Broker